All stock lists
Cytokinetics Inc (NASDAQ:CYTK)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
61.24+0.01 (+0.01%)
Insider Score
––Not scored
CYTK Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CYTK Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 31.91 M | 19.36 M | 17.75 M | 1.94 M | 66.77 M | 1.58 M |
| Revenue Growth (YoY) | -52.20 % | 1125.78 % | 4.89 % | 318.14 % | 26714.86 % | 89.10 % |
| Cost of Revenue | 2.73 M | 2.39 M | 2.86 M | 2.68 M | 2.29 M | 99.84 M |
| Gross Profit | 29.18 M | 16.96 M | 14.89 M | -743.00 K | 64.48 M | -98.26 M |
| SG&A Expense | 104.40 M | 104.90 M | 91.72 M | 69.46 M | 65.72 M | 57.37 M |
| R&D Expense | 97.81 M | 95.53 M | 101.54 M | 99.23 M | 112.55 M | 99.84 M |
| Operating Expenses | 205.06 M | 200.58 M | 193.26 M | 166.01 M | 175.99 M | 57.37 M |
| Operating Income | -175.88 M | -183.62 M | -178.37 M | -166.75 M | -111.51 M | -155.63 M |
| Pretax Income | -198.76 M | -206.03 M | -183.03 M | -306.18 M | -134.37 M | -161.38 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -198.76 M | -206.03 M | -183.03 M | -306.18 M | -134.37 M | -161.38 M |
| EPS (Basic) | -1.50 | -1.67 | -1.49 | -2.55 | -1.12 | -1.36 |
| EPS (Diluted) | -1.50 | -1.67 | -1.50 | -2.55 | -1.12 | -1.36 |
| Shares Outstanding | 132.09 M | 123.27 M | 122.02 M | 119.98 M | 119.46 M | 118.50 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.